Nurix Therapeutics Inc Sustainability Reports
Nurix Therapeutics is a biopharmaceutical company discovering and developing targeted protein degradation medicines for cancer and inflammatory diseases.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
FIGI: BBG00SDJ8M87
1 reports from 2023 to 2023
Company Profile
Nurix Therapeutics is a biopharmaceutical company discovering and developing targeted protein degradation medicines for cancer and inflammatory diseases.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
